Skip to Main Content

SAN FRANCISCO — At a J.P. Morgan Healthcare Conference that’s been dominated by talk of the hurdles that women face in the industry, GlaxoSmithKline’s (GSK) Emma Walmsley, a rare female CEO of a big pharmaceutical company, got a timely question.

How do you think about cultivating diversity in GSK’s leadership?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!